Gabather AB (publ)

kr 0.02As of Sun 8 Nov 2026, 12:00 UTC
STO:GABAHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (53.66%)
Div yield —
ROE (2242.08%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.65)
PE TTM —
TSR TTM (44.02%)
Mkt cap kr 12.58M
ROIC (1365.89%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.0207
0.62%
(50.51%)
Hold 12|2|1|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
3.29%
3.95%
2.64%
6.69%
Revenuekr M
0.762
0.799
0.793
0.812
9.62%
11.30%
4.79%
5.44%
Peers (US$1.271M)
Cap (US$)
PE
4.830M
0.121x
1.268M
—
Capital
TTM
5Y
10Y
Leveragex
0.233
0.283
0.278
EBIT/Intx
3.150
0.473
0.477
Own earn%
29.00
85.62
78.66
Sh yield%
27.92
40.84
40.36
Owners
Insiders/Inst%
13.15
82.52
Short interest%
5.43
SBC / revenue%
0.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
15–23
$1 testx
−0.1
Incr. ROIC%
2